News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,578 Results
Type
Article (49421)
Company Profile (314)
Press Release (677843)
Section
Business (212105)
Career Advice (2090)
Deals (36509)
Drug Delivery (98)
Drug Development (83477)
Employer Resources (169)
FDA (16914)
Job Trends (15681)
News (358869)
Policy (34616)
Tag
Academia (2758)
Alliances (51440)
Alzheimer's disease (1342)
Approvals (16875)
Artificial intelligence (180)
Bankruptcy (366)
Best Places to Work (12067)
Biotechnology (216)
Breast cancer (212)
Cancer (1573)
Cardiovascular disease (128)
Career advice (1751)
CAR-T (109)
Cell therapy (319)
Clinical research (66862)
Collaboration (593)
Compensation (309)
COVID-19 (2677)
C-suite (141)
Data (1492)
Diabetes (196)
Diagnostics (6413)
Earnings (87162)
Employer resources (147)
Events (115332)
Executive appointments (504)
FDA (17718)
Funding (533)
Gene therapy (219)
GLP-1 (672)
Government (4609)
Healthcare (19825)
Infectious disease (2777)
Inflammatory bowel disease (119)
Interviews (317)
IPO (16761)
Job creations (4040)
Job search strategy (1497)
Layoffs (442)
Legal (8424)
Lung cancer (234)
Manufacturing (220)
Medical device (14232)
Medtech (14237)
Mergers & acquisitions (20010)
Metabolic disorders (526)
Neuroscience (1722)
NextGen: Class of 2025 (6905)
Non-profit (4731)
Northern California (1888)
Obesity (303)
Opinion (200)
Patents (134)
People (59499)
Phase I (20790)
Phase II (29383)
Phase III (21949)
Pipeline (619)
Postmarket research (2740)
Preclinical (8842)
Radiopharmaceuticals (249)
Rare diseases (295)
Real estate (6291)
Regulatory (23203)
Research institute (2474)
Resumes & cover letters (359)
Southern California (1636)
Startups (3821)
United States (17088)
Vaccines (617)
Weight loss (220)
Date
Today (117)
Last 7 days (433)
Last 30 days (1994)
Last 365 days (35690)
2025 (1866)
2024 (36144)
2023 (41146)
2022 (52382)
2021 (57102)
2020 (55916)
2019 (48803)
2018 (36941)
2017 (33760)
2016 (33573)
2015 (39619)
2014 (33333)
2013 (28567)
2012 (30850)
2011 (31563)
2010 (29925)
Location
Africa (789)
Arizona (211)
Asia (40559)
Australia (6680)
California (4310)
Canada (1571)
China (372)
Colorado (201)
Connecticut (218)
Europe (87708)
Florida (613)
Georgia (155)
Illinois (448)
Indiana (248)
Maryland (718)
Massachusetts (3360)
Michigan (188)
Minnesota (329)
New Jersey (1212)
New York (1222)
North Carolina (848)
Northern California (1888)
Ohio (156)
Pennsylvania (1008)
South America (1182)
Southern California (1636)
Texas (635)
Utah (124)
Washington State (441)
727,578 Results for "medical marijuana inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
December 10, 2024
·
1 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
January 8, 2025
·
7 min read
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) (“MIRA” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that MIRA-55, has been determined by the U.S. Drug Enforcement Administration (DEA) not to be a controlled substance or listed chemical under the Controlled Substance Act and its governing regulations.
May 29, 2024
·
6 min read
Press Releases
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
January 15, 2025
·
1 min read
Press Releases
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
January 17, 2025
·
6 min read
Business
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending September 30, 2022, and provided an overview of recent operational highlights.
November 22, 2022
·
3 min read
Press Releases
CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer
December 30, 2024
·
3 min read
Press Releases
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
January 21, 2025
·
8 min read
Press Releases
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
1 of 72,758
Next
